John Fox, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 800 S Ash St, Nevada, MO 64772 Phone: 417-667-3355 Fax: 417-448-3691 |
News Archive
St. Jude Medical, Inc. today announced that it has received CE Mark approval for the Trifectaâ„¢ valve, marking the Company's launch into the market for pericardial aortic stented tissue valves.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
In a paper recently uploaded to the preprint server bioRxiv by Tauzin et al. (March 18th, 2021) the ability of a single dose of mRNA vaccine to induce humoral and T cell responses against mutated variants are demonstrated and found to be reinforced in individuals with a history of COVID-19.
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
› Verified 7 days ago